Female Health Profit Margin 2006-2020 | VERU

Current and historical gross margin, operating margin and net profit margin for Female Health (VERU) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Female Health net profit margin as of March 31, 2020 is -25.53%.
Female Health Annual Profit Margins
Female Health Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.233B $0.032B
Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $158.948B 27.56
Medtronic (MDT) Ireland $136.751B 22.23
Stryker (SYK) United States $77.601B 25.19
Boston Scientific (BSX) United States $54.337B 25.55
Baxter (BAX) United States $45.238B 27.61
Lonza Group Ag (LZAGY) Switzerland $35.887B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $30.689B 0.00
Terumo (TRUMY) Japan $30.016B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.360B 17.84
ResMed (RMD) United States $23.268B 36.72
Smith & Nephew SNATS (SNN) United Kingdom $19.349B 0.00
Sunny Optical Technology (SNPTF) China $16.329B 0.00
Bio-Rad Laboratories (BIO) United States $13.416B 61.07
Insulet (PODD) United States $11.294B 1118.94
DiaSorin S.p.A (DSRLF) Italy $10.630B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $9.316B 0.00
Perrigo (PRGO) Ireland $7.580B 13.56
GN STORE NORD (GNNDY) Denmark $7.314B 37.79
Hill-Rom Holdings (HRC) United States $6.978B 19.67
William Demant Holdings (WILYY) Denmark $6.951B 0.00
Quidel (QDEL) United States $6.453B 50.71
Canopy Growth (CGC) Canada $5.792B 0.00
Haemonetics (HAE) United States $4.984B 29.94
ICU Medical (ICUI) United States $4.164B 30.38
GW Pharmaceuticals (GWPH) United Kingdom $3.978B 0.00
Neogen (NEOG) United States $3.873B 65.61
Envista Holdings (NVST) United States $3.718B 0.00
Agios Pharmaceuticals (AGIO) United States $3.490B 0.00
NuVasive (NUVA) United States $3.388B 27.21
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.066B 0.00
National Vision Holdings (EYE) United States $2.552B 44.15
AtriCure (ATRC) United States $2.014B 0.00
TG Therapeutics (TGTX) United States $2.014B 0.00
Cardiovascular Systems (CSII) United States $1.464B 0.00
Aurora Cannabis (ACB) Canada $1.418B 0.00
Aphria (APHA) Canada $1.173B 0.00
NanoString Technologies (NSTG) United States $1.151B 0.00
Phibro Animal Health (PAHC) United States $1.108B 22.08
InMode (INMD) Israel $1.084B 22.91
MacroGenics (MGNX) United States $0.981B 0.00
Cerus (CERS) United States $0.968B 0.00
PetIQ (PETQ) United States $0.860B 24.84
Omeros (OMER) United States $0.799B 0.00
Quanterix (QTRX) United States $0.735B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.725B 122.69
Zynex (ZYXI) United States $0.711B 71.43
VAREX IMAGING (VREX) United States $0.691B 17.17
Eagle Pharmaceuticals (EGRX) United States $0.677B 48.51
Meridian Bioscience (VIVO) United States $0.677B 25.48
Vapotherm (VAPO) United States $0.644B 0.00
OraSure Technologies (OSUR) United States $0.641B 129.19
Lantheus Holdings (LNTH) United States $0.581B 11.69
Surmodics (SRDX) United States $0.575B 69.25
LeMaitre Vascular (LMAT) United States $0.569B 32.44
Owens & Minor (OMI) United States $0.497B 13.15
BioLife Solutions (BLFS) United States $0.429B 150.00
Repro-Med Systems (KRMD) United States $0.413B 347.00
Utah Medical Products (UTMD) United States $0.387B 28.12
Viemed Healthcare (VMD) United States $0.332B 29.76
HEXO (HEXO) $0.329B 0.00
Cytosorbents (CTSO) United States $0.318B 0.00
Organigram Holdings (OGI) Canada $0.309B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.298B 0.00
InfuSystems Holdings (INFU) United States $0.236B 130.78
Chimerix (CMRX) United States $0.198B 0.00
Evolus (EOLS) United States $0.184B 0.00
Bovie Medical (APYX) United States $0.168B 0.00
Fonar (FONR) United States $0.162B 14.40
Exagen (XGN) United States $0.156B 0.00
Rockwell Medical (RMTI) United States $0.145B 0.00
Chembio Diagnostics (CEMI) United States $0.144B 0.00
Liberty Health Sciences (LHSIF) Canada $0.137B 0.00
Surface Oncology (SURF) United States $0.133B 0.00
United Health Products (UEEC) United States $0.130B 0.00
MTech Acquisition (KERN) United States $0.121B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.102B 0.00
Wound Management Technologies (SMTI) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
United-Guardian (UG) United States $0.076B 17.62
Brainsway (BWAY) Israel $0.075B 0.00
Nephros (NEPH) United States $0.071B 0.00
Capricor Therapeutics (CAPR) United States $0.061B 0.00
GUARDION HEALTH (GHSI) United States $0.042B 0.00
FSD PHARMA INC (HUGE) Canada $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
ImmuCell (ICCC) United States $0.032B 0.00
NF Energy Saving (BIMI) China $0.027B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.015B 0.00
Myomo (MYO) United States $0.011B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00